✦ LIBER ✦

Comparing Biomarkers as Principal Surrogate Endpoints

✍ Scribed by Ying Huang; Peter B. Gilbert

Book ID: 109224535
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 206 KB
Volume: 67
Category: Article
ISSN: 0006-341X
DOI: 10.1111/j.1541-0420.2011.01603.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers and surrogate endpoints

✍ J. K. Aronson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Regulatory surrogate endpoint biomarkers

✍ Suzanne A. Fuqua 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Imaging biomarkers as surrogate endpoint

Imaging biomarkers as surrogate endpoints for drug development

✍ Wolf S. Richter 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 100 KB

Evaluating Candidate Principal Surrogate

Evaluating Candidate Principal Surrogate Endpoints

✍ Peter B. Gilbert; Michael G. Hudgens 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

Genetic surrogate endpoint biomarkers in

Genetic surrogate endpoint biomarkers in early breast neoplasia

✍ D. Craig Allred 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Genetic Surrogate Endpoint Biomarkers in Early Breast Neoplasia "Biomarkers in Early Breast Neoplasia," presented by D. Craig Allred. The biological mechanisms of breast cancer evolution are poorly understood. Furthermore, this problem has been difficult to study because potential precursor les

Genetic surrogate endpoint biomarkers in

Genetic surrogate endpoint biomarkers in early breast neoplasia

✍ Leslie Brand 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Carolina) discussed the relationship of oncogenes and breast cancer. Specifically, he described much of the recent work with HER-2/neu, PRADI, and p53. Some of these genetic lesions appear early in the breast cancer process and are stable as the tumors become invasive and metastasize. Dr. Liu also p